Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-557 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-94 |
filingDate |
2005-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2008-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2008511541-A |
titleOfInvention |
Prostaglandin derivatives for the treatment of gastrointestinal disorders |
abstract |
The present invention relates to a method for long-term treatment of gastrointestinal disorders in a human subject comprising administering to the subject an effective amount of a halogenated prostaglandin compound and / or tautomer thereof. The method does not cause an electrolyte shift substantially during the treatment period. The compounds used in the present invention can ameliorate QOL in human subjects with gastrointestinal disorders, are equally effective in the treatment of male and female subjects, and in human subjects 65 years of age and older Is also effective. |
priorityDate |
2004-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |